Berfield Kathleen S, Wood Douglas E
Division of Cardiothoracic Surgery, Department of Surgery, University of Washington, Seattle, WA, USA.
J Thorac Dis. 2017 Apr;9(Suppl 3):S208-S210. doi: 10.21037/jtd.2017.03.135.
Advancements in the diagnosis, staging and management of lung cancer have all led to improvements in outcomes associated with sublobar resection. Lobectomy, for early stage lung cancers has been the treatment of choice for many years. However, there is mounting evidence that sublobar resection when applied to the appropriate patient population can provide not only excellent oncologic results but also equivalent survival to lobectomy. Therefore, it is time that we reevaluate the management of peripheral stage IA lung cancers.
肺癌诊断、分期及治疗方面的进展均已使肺叶下切除相关的治疗结果得到改善。多年来,肺叶切除术一直是早期肺癌的首选治疗方法。然而,越来越多的证据表明,对于合适的患者群体,肺叶下切除不仅能带来出色的肿瘤学效果,而且生存情况与肺叶切除术相当。因此,是时候重新评估外周IA期肺癌的治疗了。